StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) income statement

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca PLC income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
81.9%
Operating margin
23.4%
Net margin
17.4%
Return on equity, FY2025
22.9%

Financial strength

Current ratio
0.89
Debt to equity
0.59
Debt to assets
25.5%
Cash to current liabilities
15.5%

Valuation

P/E ratio
25.1
Price to sales
4.35
Price to book
5.09
Dividend yield
1.91%

See a number that looks wrong?